"Designing Growth Strategies is in our DNA"
The global wearable medical devices market size was valued at USD 81.15 billion in 2023. The market is projected to grow from USD 91.21 billion in 2024 to USD 324.73 billion by 2032, exhibiting a CAGR of 17.2% during the forecast period.
Wearables in healthcare encompass medical devices that customers can wear, such as activity trackers and smartwatches. They are specifically designed to monitor and collect real-time data on a user’s health and fitness. According to an article published by mHealth Intelligence in 2023, around 40% of U.S. adults are using healthcare-related applications, and 35% are utilizing wearable healthcare devices.
Recent technological advancements in wearable devices and the growing need among the population to enhance their health have motivated several market players to develop more smart devices, such as Fitbit, biosensors, and hearing aids. In addition, the increasing prevalence of chronic diseases and lifestyle-related disorders is one of the major factors anticipated to propel the sales of wearable medical devices during the forecast period.
The outbreak of the COVID-19 pandemic had an overall positive impact on the market. Manufacturers of diagnostic devices reported significant growth in their revenues during this period due to a strong demand for wearable medical devices among the population. These devices were utilized for self-monitoring the symptoms of COVID-19.
Growing Shift Toward Health Consciousness Among General Population
There is a growing awareness toward prioritization of health and well-being among the general population. Healthcare wearables, including smartwatches and fitness bands, among others, are becoming popular owing to their versatility and convenience among the general population.
Major market players are currently focusing on introducing advanced wearable devices in the market to cater to the growing needs of customers.
In addition, in May 2020, Koninklijke Philips N.V. received the U.S. FDA and CE clearance to use Biosensor BX100 in monitoring COVID-19 patients in hospitals. The biosensor was a single-use wearable patch specially designed to be integrated with a scalable hub to monitor patients across hospital rooms. This product could also be incorporated into existing clinical workflows for mobile viewing and notifications.
Request a Free sample to learn more about this report.
Growing Prevalence of Chronic Diseases to Boost the Growth of the Market
There is an increasing prevalence of chronic diseases, including hypertension, diabetes, and others, owing to sedentary lifestyle among patients, further imposing a financial burden on the healthcare systems. The growing prevalence of these chronic disorders is further driving the focus toward the provision of timely and routine diagnosis among the patient population.
Moreover, governmental organizations and healthcare agencies have been actively promoting routine diagnosis through various campaigns and awareness programs. These initiatives have resulted in an increased awareness of products and devices for diagnosing and monitoring vital signs among the general population.
The aforementioned factors, coupled with the introduction of vital sign monitoring devices that measure heart rate, SpO2, and blood glucose levels by market players, have led to a significant rise in demand for these devices among the general population and patients.
High Cost of Maintenance of Wearable Devices May Limit Their Adoption
There is a vast advancement in the technology of wearable devices, boosting their adoption among the general population. However, the high cost associated with the maintenance of these wearable devices is anticipated to limit their adoption in the market. The periodic replacement of chips, sensors, batteries, and other accessories equipped in these devices increases their overall cost among the population. These factors, coupled with limited reimbursement policies for these devices, have contributed to their limited adoption in both developed and emerging countries.
Increasing Prevalence of Chronic Diseases Globally to Boost Use of Diagnostic & Patient Monitoring Devices
By product, the market is bifurcated into diagnostic & monitoring devices and therapeutic devices.
The diagnostic & monitoring devices segment dominated the global wearable medical devices market share in 2023. The growing prevalence of chronic diseases, including diabetes, cardiac disorders, among others, is further driving the growing focus of key players to introduce new advanced products for diagnosis and patient monitoring, thus supporting segmental growth. This, along with increasing disposable income among the population, is further likely to support the growth of the segment in the market.
On the other hand, the therapeutic devices segment is expected to grow significantly during the forecast period. The growth is due to the distinct benefits offered by these devices, such as ease of use, precise dosing, and the ability to perform multiple functions at a time.
To know how our report can help streamline your business, Speak to Analyst
Advent of New and Advanced Wearable Devices to Boost Their Use in Sports & Fitness
By application, the market is categorized into remote patient monitoring & home healthcare and sports & fitness.
The sports & fitness segment dominated the market in 2023. The growth is due to increasing awareness about the certain benefits associated with these wearable medical devices used for sports & fitness activities, such as efficient and easy tracking of heart rate, among others, further resulting in the rising adoption of these devices among the population. This, along with a growing preferential shift toward sports & fitness activities, is resulting in the rising focus of key players to launch advanced products in the market, thereby contributing to the growth of the segment in the market.
On the other hand, the remote patient monitoring & home healthcare segment held the second-largest share in 2023. The growing geriatric population in both developed and emerging countries, coupled with the increasing prevalence of chronic diseases among elderly patients, is anticipated to surge the growth of this segment during the forecast period.
Consumer Grade Segment Dominated the Market Owing to Increasing Adoption of These Products
Based on grade, the market is divided into consumer grade and clinical grade.
The consumer grade segment held the largest market share in 2023. The growth is due to certain factors, such as increasing demand for consumer-grade products such as fitness bands, smartwatches, and smart clothing, among others, resulting in the rising adoption of these products in the market. This, along with an increasing number of players in the wearable medical devices market focusing on product launches, collaborations, and mergers among the key players to strengthen their presence, is likely to support the growth of the segment in the market.
On the other hand, the clinical grade segment is expected to grow with the highest CAGR during the forecast period. The growth is due to a rising focus on regulatory approvals, resulting in a growing number of product launches in the market for clinical-grade wearables.
Retail Pharmacies Segment Led Due to High Demand for Self-Monitoring Diagnostic Devices
In terms of distribution channel, the market for wearable medical devices is segmented into retail pharmacies, online distribution, and hypermarkets & others.
The retail pharmacies segment held a dominant share of the global market in 2023 and is likely to record a higher CAGR during the forecast period. The segmental dominance is attributed to the increasing demand for self-monitoring, non-invasive monitoring, and diagnostic devices among the population. The strong focus of market players on retail channels in emerging countries is further driving the segment growth.
The online distribution segment is expected to register a significant CAGR during the forecast period owing to the increasing shift of customers in metropolitan cities toward e-commerce platforms for purchasing wearable devices.
By region, the market for wearable medical devices is divided into Europe, North America, the Asia Pacific, and the rest of the world.
North America Wearable Medical Devices Market Size, 2023 (USD Billion)
To get more information on the regional analysis of this market, Request a Free sample
The North America dominated the market and was valued at USD 37.40 billion in 2023. The growth is due to certain factors, including adequate reimbursement policies, higher per capita expenditure on advanced technologies, coupled with the constant focus of market players on the introduction of innovative wearable devices in the U.S. This, along with well-established diagnostic infrastructure and strong adoption of technologically advanced products by end-users in the region is contributing to the market growth.
The Asia Pacific is anticipated to record the highest CAGR during the forecast period, especially in developing countries such as India, South Korea, Australia, and China. This is primarily due to the increasing focus of governments and NGOs in China and Japan on reducing patients’ hospital stays.
On the other hand, the Europe market for wearable medical devices is also expected to grow during the forecast period. The growth is due to the rising geriatric population, resulting in the growing prevalence of chronic disorders, including diabetes, cardiovascular disorders, among others. The rising prevalence of these disorders, along with the growing demand for wearable devices, is driving the focus of key players on R&D activities to launch advanced products in the market.
The rest of the world accounted for a comparatively lower market share in 2023, as it is a vast and untapped market. However, improvement in healthcare expenditure and increasing adoption of advanced wearable devices in Latin America and the Middle East & Africa are expected to lead this market to future growth prospects.
Apple Inc. Held Dominant Market Share Due to Its Robust Portfolio of Smart Products
The competitive landscape of the global wearable medical devices market is highly competitive, with the presence of major players such as Apple Inc., SAMSUNG, Fitbit Inc., and Sonova, among others. With its robust portfolio of activity trackers and smartwatches, Apple Inc. accounted for a dominant share of the global market in 2023. In addition, through various collaborations and acquisitions, key players are strengthening their market positions.
Other players operating in this market include Sonova, OMRON Corporation, BD, and NeuroMetrix Inc. These companies are continuously focusing on the development of advanced therapeutic wearables and expanding their distribution channels globally to establish their foothold in emerging countries.
An Infographic Representation of Wearable Medical Devices Market
To get information on various segments, share your queries with us
The report provides a detailed analysis of the wearable medical devices market and focuses on key aspects, such as leading companies, applications, products, grade, and distribution channels. Moreover, it offers insights into the latest market trends and highlights key industry developments. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the growth of the market in recent years.
To gain extensive insights into the market, Request for Customization
ATTRIBUTE | DETAILS |
Study Period | 2019-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2019-2022 |
Growth Rate | CAGR of 17.2% from 2024 to 2032 |
Unit | Value (USD billion) |
Segmentation | By Product
|
By Application
| |
By Grade
| |
By Distribution Channel
| |
By Region
|
Fortune Business Insights says that the global market value stood at USD 81.15 billion in 2023 and is projected to reach USD 324.73 billion by 2032.
In 2023, the North America market value stood at USD 37.40 billion.
The market is slated to exhibit a CAGR of 17.2% during the forecast period.
By product, the diagnostic & monitoring devices segment dominated the market in 2023.
The increasing prevalence of chronic diseases and growing awareness regarding self-monitoring and diagnosis are the key drivers of the market.
Apple Inc., Fitbit Inc., and Sonova are the top players in the market.
North America held the largest share in the market in 2023.
The continuous introduction of novel products and optimization of existing products for diagnosis and self-monitoring devices around the globe are expected to drive the adoption of wearable medical devices.
US +1 833 909 2966 ( Toll Free )